CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma
Kiyohiro Ando(Saitama Cancer Center), Satoshi Wada(SHOWA Medical University)
Cited by 7
Related Papers
Ring Finger Protein 43 as a New Target for Cancer Immunotherapy
|Clinical Cancer Research|2004|55
Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells
|International Journal of Molecular Sciences|2019|24
The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments
|International Journal of Molecular Sciences|2022|17
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
|Oncology Letters|2023|14
DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells
|International Journal of Molecular Sciences|2023|0